Immunohistochemistry Market Research, 2031
The global Immunohistochemistry Market size was valued at $2.4 billion in 2021, and is projected to reach $4.5 billion by 2031, growing at a CAGR of 6.5% from 2022 to 2031. Immunohistochemistry is a valuable technique that is used for the identification and visualization of tissue antigens in biological research and clinical diagnostics. In addition, immunohistochemistry (IHC) is a diagnostic technique, which is conducted in a laboratory. It involves performing special tests on the biopsy tissue sample to help diagnose various types of diseases more precisely.
The key factors that drive the Immunohistochemistry Market growth are an increase in the prevalence of chronic diseases and the rise in the geriatric population in developed nations. For instance, according to a report published in the Centers for Disease Control & Prevention in 2021, cancer is the leading cause of death and may soon become the leading cause of death in the U.S.Moreover, the increase in research & development activities in immunohistochemistry and the surge in collaboration between regulatory outsourcing and pharma & biotech companies propel the growth of the market. However, a lack of skilled professionals as well as a trained workforce with cross-functional skills are expected to hinder the growth of the immunohistochemistry market during the forecast period
Immunohistochemistry market segmentation
The global Immunohistochemistry Market size was valued at $2.4 billion in 2021, and is projected to reach $4.5 billion by 2031, growing at a CAGR of 6.5% from 2022 to 2031. .The immunohistochemistry market is segmented into product, application, end-user, and region. By product, the market is categorized into antibodies, reagents, equipment, and kits. The antibody segment is further classified into primary antibody and secondary antibody. The reagent segment is further classified into histological stains, blocking sera and reagents, chromogenic substrates, fixation reagents, organic solvents, proteolytic enzymes, diluents, and other reagents. The equipment segment is further categorized into slide-staining systems, tissue processing systems, slide scanners and others. The kits segment is further divided into IHC kits for human tissue and IHC kits for animal tissue.
By application, the market is segmented into diagnosis, research application, and forensics. The diagnosis segment is further fragmented into cancer, infectious diseases, autoimmune diseases, nephrological diseases, neurological diseases, and other diseases. The research application is further classified into drug testing and others.By end user, the market is categorized into hospitals & diagnostic laboratories, academic & research institutes, and other end users .By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Product Segment review
By product, the immunohistochemistry market is segmented into antibodies, reagents, kits, and equipment. The antibodies segment accounted for the largest share of the market. The dominance of this segment can be attributed to an increase in the use of primary and secondary antibodies in immunohistochemistry tests for the diagnosis of disease.
The reagents segment is anticipated to grow at a significant rate during the forecast period owing to an increase in demand for advanced immunohistochemistry systems for clinical diagnosis.
Application Segment Review
By application, the Immunohistochemistry Industry is segmented into diagnosis, research application, and forensics. The diagnosis segment was the highest revenue contributor to the market, owing to an increase in the prevalence of various chronic diseases such as cancer and diabetes.
The research segment is expected to grow at a considerable growth rate during the immunohistochemistry market forecast period. Owing to the rise in research & development activities by pharmaceutical companies for the research of innovative drugs.
End User Segment Review
By end user, the market is categorized into hospitals & diagnostic laboratories, academic & research institutes, and other end users. The hospitals & diagnostic laboratories segment was the highest revenue contributor to the market. Owing to the rise in the prevalence of chronic diseases such as cancer, cardiovascular disease, heart disease, asthma, and chronic obstructive pulmonary disease and an increase in the number of patient visits to the hospital for diagnosis of various chronic diseases.
Region Segment Review
Region-wise, the immunohistochemistry market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for a majority of the immunohistochemistry market share in 2021 and is anticipated to remain dominant during the forecast period. This is attributed to rising in the number of chronic disease cases, the presence of key players, and advancements in healthcare in the region. For instance, six in ten Americans live with at least one chronic disease, such as heart disease, stroke, cancer, or diabetes, which are leading causes of death and disability and they are also a leading driver of the healthcare costs in this region.
Asia-Pacific is anticipated to witness lucrative growth, owing to an increase in medical tourism, implementation of new ICT guidelines in Japan, investments, and reforms to modernize China’s healthcare infrastructure, rapid growth in the healthcare industry in India support the market growth in this region.
Key players that operate in the immunohistochemistry market are Abcam PLC, Agilent Technologies Inc, Becton, Dickinson & Company, Biocare Medical LLC, Biogenex Laboratories, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc, Diagnostic Biosystems Inc., Eagle Biosciences Inc, F. Hoffman-La Roche AG, Genemed Biotechnologies Inc, Merck KGaA, Miltenyi Biotec GmbH, PerkinElmer Inc, Rockland Immunochemicals Inc, Takara Bio. Inc, and Thermofisher Scientific, Inc
The immunohistochemistry market is segmented into Product, Application and End User.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the immunohistochemistry market analysis from 2021 to 2031 to identify the prevailing immunohistochemistry market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the immunohistochemistry market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global immunohistochemistry market trends, key players, market segments, application areas, and market growth strategies.
Immunohistochemistry Market Report Highlights
| Aspects | Details |
 By Product |
|
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | Biocare Medical, LLC, Thermofischer Scientific Inc, Merck Kgaa, Eagle Biosciences, Inc., F hoffman La Roche, Sakura Finetek Japan Co., Ltd, Miltenyi Biotec, Bio SB, Biogenex Laboratories, CANDOR Bioscience GmbH, Elabscience, Inc., Cell Signaling Technology, Inc, PHC Holdings Corporation, Takara Bio, Inc, Abcam Plc, Agilent Technologies Inc, Biorad Laboratories |
 Other Players | Medtronic Plc |
Analyst Review
This section provides various opinions of top-level CXOs in the immunohistochemistry market. In accordance with several interviews conducted, the immunohistochemistry market is expected to witness significant growth in the future, owing to an increase in the prevalence of cancer patients.
According to the perspectives of CXOs, the global immunohistochemistry market is expected to witness steady growth in the future. Rise in the geriatric population, and an increase in the number of chronic diseases such as cardiovascular diseases, heart disease, diabetes, cancer, infectious disease, asthma, ulcerative colitis, and kidney diseases. In addition, the rise in the prevalence of infectious dishes such as COVID infections across the world further propels the growth of the market. However, a lack of skilled professionals is expected to hamper the growth of the market up to some extent during the forecast period.
On the contrary, a rise in advancements in technical skills and an increase in the number of product approvals are expected to provide opportunities for the growth of the global chronic disease management market in the future.
Further, North America is expected to witness the highest growth, in terms of revenue, owing to an increase in technological advancement and an increase in the prevalence of chronic diseases.
Asia-Pacific was the second largest contributor to the market in 2021 and is expected to register the fastest CAGR during the forecast period, owing to an increase in the geriatric population.
The upcoming trends in the Immunohistochemistry Market are an increase in the prevalence of the geriatric population, a rise in the prevalence of chronic disease, and a rise in healthcare expenditure boosts the market growth.
The total market value of the Immunohistochemistrymarket is $4,530.56 million in 2031
North America is the largest regional market for Immunohistochemistry.
$2,388.5 0 million is the estimated industry size of Immunohistochemistry in 2021
The top companies to hold the market share in Immunohistochemistry areAbcam PLC, Agilent Technologies Inc, Becton, Dickinson & Company, Biocare Medical LLC, Biogenex Laboratories, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc
The base year for the report is 2021
No, there is a value chain analysis provided in the Immunohistochemistrymarket report
The forecast period in the report is from 2022 to 2031
Loading Table Of Content...
